CEO Monthly Issue 5 2018

CEO MONTHLY / ISSUE 5 2018 15 Evolve is Solving Dysbiosis of the Newborn Gut Microbiome Company: Evolve BioSystems Contact: David Kyle Address: 2121 2nd St, Suite C108, Davis, California, 95618, USA Phone: 001 530 747 2012 Website: www.evolvebiosystems.com www.evivo.com With all babies worldwide facing the same issues regardless of race, colour, creed, economics or location, the team is working exceptionally hard to ensure all babies have the right to a better world. David tells us what his plans are currently and in his concluding comments, he mentions what projects are in the pipeline for the committed and dedicated team at Evolve. “Presently, I am fully engaged in bringing a new concept of nutrition and disease prevention to the world. I believe that the maldevelopment of the immune system and metabolic set points due to a disruption in the microbiome in the first few months of life, may be the primary cause for the global pandemic of autoimmune disorders and obesity. “Ultimately, this is a bold speculation based mostly on correlational evidence and a belief that nature does not make mistakes. But if we are right in this speculation, and the reestablishment of the natural infant gut microbiome early in life returns the prevalence of food allergies, asthma, Type I Diabetes, Celiac Disease, and obesity to the low levels found 50-60 years ago, this could have one of the greatest impacts on worldwide public health since the development of vaccines. My future aspiration is to make this happen quickly and safely, and to start improving the lifelong health trajectories of all babies worldwide as soon as possible.”